BFA
FLNA

BlackRock Fund Advisors’s Filana Therapeutics FLNA Stock Holding History

BlackRock Fund Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$57K Buy
14,219
+436
+3% +$2.02K ﹤0.01% 3742
2016
Q3 		$96K Sell
13,783
-5
-0% -$83 ﹤0.01% 3632
2016
Q2 		$211K Sell
13,788
-237
-2% -$3.76K ﹤0.01% 3431
2016
Q1 		$219K Sell
14,025
-1,041
-7% -$13.5K ﹤0.01% 3427
2015
Q4 		$185K Buy
15,066
+547
+4% +$7.24K ﹤0.01% 3562
2015
Q3 		$186K Sell
14,519
-384
-3% -$4.85K ﹤0.01% 3491
2015
Q2 		$180K Sell
14,903
-134,999
-90% -$1.85M ﹤0.01% 3562
2015
Q1 		$1.98M Sell
149,902
-1,195
-0.8% -$16.1K ﹤0.01% 3128
2014
Q4 		$2.15M Buy
151,097
+20,936
+16% +$362K ﹤0.01% 3152
2014
Q3 		$3.56M Sell
130,161
-5,439
-4% -$165K ﹤0.01% 2942
2014
Q2 		$5.46M Buy
135,600
+119,933
+766% +$4.44M ﹤0.01% 2786
2014
Q1 		$603K Buy
15,667
+1,900
+14% +$67.1K ﹤0.01% 3234
2013
Q4 		$468K Sell
13,767
-70,600
-84% -$1.87M ﹤0.01% 3241
2013
Q3 		$1.61M Buy
84,367
+12,455
+17% +$218K ﹤0.01% 3149
2013
Q2 		$1.11M Buy
+71,912
New +$1.52M ﹤0.01% 3148

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

BlackRock Fund Advisors's FLNA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Filana Therapeutics (FLNA) stake by 3.2% in Q4 2016, buying an estimated $2.02K and bringing the position to 14,219 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3742.

BlackRock Fund Advisors first reported a position in FLNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.46M in Q2 2014. 46 funds tracked by Wall St. Rank hold FLNA as of Q4 2016.

  • BlackRock Fund Advisors held 14,219 shares of Filana Therapeutics worth $57K as of Q4 2016.
  • BlackRock Fund Advisors bought 436 Filana Therapeutics shares in Q4 2016, an estimated $2.02K.
  • Filana Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3742 holding.
  • BlackRock Fund Advisors first reported a position in Filana Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Filana Therapeutics position peaked at $5.46M in Q2 2014.
  • 46 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.